Search
Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.
Hogan Lovells Publications
31 January 2018
U.S. based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions.
Hogan Lovells Publications
21 August 2017
U.S.-based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions. In this series, members of...
Published Works
10 March 2010
The global economic crisis has led practitioners to extend the use of mechanisms that allow either adjustment of the terms of M&A agreements to reflect the changed economic environment...
Published Works
03 February 2010
In view of the financial crisis and the difficulty of obtaining bank loans, many companies have resorted to alternative solutions in order to maintain or increase their market presence. The ...
Published Works
03 June 2009
When acquiring a French listed or non-listed company, stock option and free share plans - instruments that have been set up in order to motivate employees and company management -should be...
Published Works
24 September 2008
Over six months late, and after receiving a reminder from the European Commission, France has finally transposed into law the EU Cross-Border Mergers Directive. This article considers...
Published Works
03 March 2008
The cross-border mergers directive, which was due to be implemented in France by December 15, 2007, is still pending, and not without consequence.
Published Works
01 May 2007
This article looks at cross-border mergers in Europe.
